TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
NTHI

NeOnc Technologies Holdings, Inc.

Healthcare · Biotechnology

3.40$ +14.0% vs. previous close Closing price · As of: Sep 17, 2026

Investor relations

Report Dates

Investor relations overview for NeOnc Technologies Holdings, Inc. (NTHI): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 08/17/2026.

Next report 08/17/2026
Last report 08/10/2026
Earnings surprise by quarter (%)
Q4 25 · -93.5 % 25 Q1 26 · -171.4 % 26 Q2 26 · -262.5 % 26

EPS estimate beaten

Full history 0 of 4 quarters (0%)

Earnings Call Transcripts

Search all transcripts →

No transcripts yet — they will show up here automatically after the next earnings call.

News on This Stock

  • 09/17/2026 NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI): Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Open ↗
  • 09/10/2026 NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI): Entry into a Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Open ↗
  • 08/20/2026 NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI): Submission of Matters to a Vote of Security Holders · sec.gov Open ↗
  • 08/13/2026 NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI): Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Open ↗
  • 08/12/2026 NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI): Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Open ↗
  • 08/10/2026 NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI): Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Open ↗
  • 07/15/2026 NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI): Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?